Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28215974 | 0.96 | TP53 (0.36) | TP53 | |
| SCHEMBL16719463 | 0.74 | TBXAS1 (0.56) | — | |
| SCHEMBL27910344 | 0.73 | TP53 (0.53) | TP53 | |
| SCHEMBL27390057 | 0.69 | HRH3 (0.37) | — | |
| SCHEMBL1680345 | 0.67 | — | — | |
| SCHEMBL2332259 | 0.67 | — | — | |
| SCHEMBL1898955 | 0.67 | — | — | |
| SCHEMBL236564 | 0.67 | — | — | |
| SCHEMBL1680305 | 0.67 | — | — | |
| SCHEMBL6159484 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119677351-A | Display device | 三星显示有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118086905-A | Reaming liquid medicine for magnesium alloy surface treatment | 重庆博昶电子科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-111187271-B | Porphyrin organic small molecule receptor material, preparation method thereof and application thereof in organic solar cell | 华南理工大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111187271-A | Porphyrin organic small molecule receptor material, preparation method thereof and application thereof in organic solar cell | 华南理工大学 | 2020-05-22 | — | — | CN | claimed |
| EP-2573124-B1 | PORPHYRIN COPOLYMER CONTAINING QUINOXALINE UNIT, PREPARATION METHOD AND USES THEREOF | OCEANS KING LIGHTING SCIENCE (CN) | 2015-08-12 | — | — | EP | claimed |
| CN-104091816-A | Polymer dielectrics for memory element array interconnect | SPANSION LLC | 2014-10-08 | — | — | CN | claimed |
| EP-2551271-B1 | COPOLYMER CONTAINING FLUORENYLPORPHYRIN-BENZENE, PREPARATION METHOD AND USE THEREOF | OCEANS KING LIGHTING SCIENCE (CN) | 2014-08-27 | — | — | EP | claimed |
| US-8604147-B2 | Porphyrin copolymer containing quinoxaline unit, preparation method and uses thereof | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2013-12-10 | — | — | US | claimed |
| US-8546512-B2 | Copolymer containing fluorenylporphyrin-benzene, preparation method and use thereof | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2013-10-01 | — | — | US | claimed |
| EP-2573124-A1 | PORPHYRIN COPOLYMER CONTAINING QUINOXALINE UNIT, PREPARATION METHOD AND USES THEREOF | Ocean's King Lighting Science&Technology Co., Ltd. (CN) | 2013-03-27 | — | — | EP | claimed |
| EP-2551271-A1 | COPOLYMER CONTAINING FLUORENYLPORPHYRIN-BENZENE, PREPARATION METHOD AND USE THEREOF | Ocean's King Lighting Science&Technology Co., Ltd. (CN) | 2013-01-30 | — | — | EP | claimed |
| US-20120329979-A1 | COPOLYMER CONTAINING FLUORENYLPORPHYRIN-BENZENE, PREPARATION METHOD AND USE THEREOF | OCEAN'S KING LIGHTING SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2012-12-27 | — | — | US | claimed |
| US-20080281091-A1 | Process for the Preparation of Porphyrin Derivatives as Antimicrobial Agents by Photodynamic Therapy (Pdt) | BRUNDISH DEREK | 2008-11-13 | — | — | US | claimed |
| EP-1963333-A1 | PROCESS FOR THE PREPARATION OF PORPHYRIN DERIVATIVES AS ANTIMICROBIAL AGENTS BY PHOTODYNAMIC THERAPY (PDT) | Destiny Pharma Limited (GB) | 2008-09-03 | — | — | EP | claimed |
| WO-2007074340-A1 | PROCESS FOR THE PREPARATION OF PORPHYRIN DERIVATIVES AS ANTIMICROBIAL AGENTS BY PHOTODYNAMIC THERAPY (PDT) | DESTINY PHARMA LIMITED (GB) | 2007-07-05 | — | — | WO | claimed |
| US-7173138-B2 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-06 | — | — | US | claimed |
| EP-1383777-B1 | LIGANDS FOR PNICOGEN CHELATE COMPLEXES WITH A METAL OF SUBGROUP VIII AND USE OF THE COMPLEXES AS CATALYSTS FOR HYDROFORMYLATION, CARBONYLATION, HYDROCYANATION OR HYDROGENATION | BASF AG (DE) | 2005-11-16 | — | — | EP | claimed |
| US-20040110960-A1 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | claimed |
| US-5876864-A | Fluorene-based alternating polymers containing acetylene group and electroluminescence element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 1999-03-02 | — | — | US | claimed |
| EP-0335754-B1 | PROCESS FOR THE PRESULFURISATION AND ACTIVITY CONTROL OF A HYDROCARBON TREATMENT CATALYST | EURECAT EUROPEENNE DE RETRAITEMENT DE CATALYSEURS (FR) | 1991-06-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110960-A1 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | OGG1, HPD, HPGD | TP53 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.